Skip to main content
HuBei NengTer Technology CO.,Ltd logo

HuBei NengTer Technology CO.,Ltd — Investor Relations & Filings

Ticker · 002102 ISIN · CNE000001Q28 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 3,004 across all filing types
Latest filing 2022-05-25 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 002102

About HuBei NengTer Technology CO.,Ltd

https://www.guanfu.com

HuBei NengTer Technology CO.,Ltd specializes in the research, development, and large-scale production of fine chemicals and pharmaceutical intermediates. The company is a prominent global supplier of key intermediates for Vitamin E, including trimethylhydroquinone and isophytol, utilizing proprietary catalytic technologies. Its product portfolio also encompasses high-end chiral chemicals and intermediates for cardiovascular medications, such as statins. HuBei NengTer focuses on technological innovation in chemical synthesis, aiming for high-efficiency and environmentally sustainable manufacturing processes. The company serves international markets, providing essential raw materials for the pharmaceutical, nutraceutical, and animal nutrition sectors.

Recent filings

Filing Released Lang Actions
长江证券承销保荐有限公司关于冠福控股股份有限公司详式权益变动报告书之财务顾问核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed financial advisor's verification opinion on a "详式权益变动报告书" (Detailed Equity Change Report) related to a significant equity change involving a listed company (冠福控股股份有限公司). It references compliance with Chinese securities laws, the Securities Regulatory Commission, and specific disclosure standards for equity change reports. The content includes extensive due diligence, verification of the equity change, shareholder structure, control relationships, and future plans related to the equity change. It is not a general annual or quarterly report, nor an earnings release or call transcript. It is not a proxy solicitation or voting results announcement. The document is a formal audit or verification opinion on a specific equity change report, which fits the category of Audit Report / Information (AR) as it is a standalone audit/verification report related to a regulatory equity change filing, not the equity change report itself or a simple announcement. The document length (15,000 characters) and detailed content confirm it is the report itself, not just an announcement or certification letter. Therefore, the best classification is AR (Audit Report / Information). FY 2022
2022-05-25 Chinese
关于大股东陈烈权先生部分股份解除质押的公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement regarding the partial release of pledged shares by a major shareholder, Mr. Chen Liequan. It details the number of shares released from pledge, the pledge status before and after the release, and the associated risks. The document is short (1370 characters) and focuses on share pledge status and shareholder information rather than financial results or management changes. It does not contain financial statements or detailed financial data. This type of announcement fits the category of a Major Shareholding Notification, as it informs about changes in significant share ownership or share pledge status by a major shareholder.
2022-05-23 Chinese
关于（2019）京0105民初29709号案件的进展公告
Legal Proceedings Report Classification · 95% confidence The document is a public announcement by a company regarding the progress of a specific legal case involving the company and its former controlling shareholder. It details the background of the case, recent developments, potential impacts on the company's profits, risk warnings, and references to previous related disclosures. The document does not contain financial statements, audit opinions, or detailed financial data. It is primarily a legal proceedings update and risk disclosure related to litigation and settlement. Therefore, it fits best under the category of Legal Proceedings Report (LTR). The document length is 2265 characters, which is relatively short and focused on legal matters rather than financial reporting or management discussion.
2022-05-22 Chinese
关于重大资产重组限售股份上市流通的提示性公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement from a listed company regarding the lifting of restrictions on certain shares previously subject to lock-up due to a major asset restructuring. It details the number of shares becoming freely tradable, the shareholders involved, compliance with regulatory commitments, and the resulting changes in share capital structure. The document references regulatory approvals and compliance with stock exchange rules but does not contain financial statements or detailed financial analysis. The length is 3376 characters, which is relatively short and the content is focused on the announcement of share unlocking and circulation rather than a full financial report or audit. Therefore, this document fits best as a Regulatory Filing (RNS) because it is a regulatory announcement about share circulation and compliance, not a full report or financial statement.
2022-05-22 Chinese
国金证券股份有限公司关于冠福控股股份有限公司重大资产重组部分限售股份解禁上市流通的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed independent financial advisor's verification opinion regarding the unlocking and circulation of restricted shares related to a major asset restructuring of a listed company. It references regulatory approvals, share issuance details, shareholder commitments, and compliance with relevant securities laws and stock exchange rules. The document is not a full annual or interim financial report, nor is it a simple announcement or certification. It is a specialized audit-related report focusing on the verification of share unlocking and compliance with asset restructuring rules. Therefore, it fits best under the category of Audit Report / Information (AR). The document length (6324 characters) and detailed content support this classification with high confidence. Q2 2022
2022-05-22 Chinese
独立董事关于公司子公司向大股股东借款暨关联交易的事前同意函
Regulatory Filings Classification · 95% confidence The document is a formal letter from independent directors of a company regarding their prior consent on a related-party transaction involving loans from major shareholders to subsidiaries. It references regulatory rules and internal governance documents, and it is a statement of opinion and approval rather than a full report or financial statement. The document length is short (718 characters), and it is a specific consent letter related to governance and compliance with listing rules. It does not contain financial data or detailed financial results, nor is it an announcement of a report publication. This fits best under Regulatory Filings (RNS), which covers compliance documents and miscellaneous filings that do not fit other categories.
2022-05-19 Chinese

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.